Perrigo Announces FDA Final Approval for its AB Rated Generic Version of Mycolog(R) II Cream
DUBLIN, Aug. 16, 2017 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received final approval from the U.S. Food and Drug Administration for its AB rated Abbreviated New Drug Application referenci... Biopharmaceuticals, Generics, FDA Perrigo, Mycolog, nystatin, triamcinolone acetonide, candidiasis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Food and Drug Administration (FDA) | Marketing | New Drug Applications | Nystatin | Pharmaceuticals | Triamcinolone